Advanced filters coming soon.

Latest Stories

11 Dec 2025

S&C Advises Icade on Sale of Majority Stake in 23-Asset Italian Healthcare Portfolio Worth More Than €300 Million

S&C advised Icade on the sale of its majority stake in a diversified portfolio of 23 healthcare and senior assisted‑living assets in northern and ce...

Read more →
11 Dec 2025

Kirkland & Ellis Advises Avocet Partners on Acquisition of EMC Life

Kirkland & Ellis advised Avocet Partners on a definitive agreement to acquire EMC National Life Insurance Company (EMC Life) following a contemplated ...

Read more →
11 Dec 2025

Latham & Watkins Advises Initial Purchasers on Antero Midstream's Upsized US$600 Million Private Senior Notes Offering

Latham & Watkins LLP advised the initial purchasers in Antero Midstream Corporation’s upsized US$600 million private placement of senior unsecured n...

Read more →
11 Dec 2025

Latham & Watkins Advises Repsol on Second Renewable Asset Rotation with Stonepeak in the US

Latham & Watkins LLP advised Repsol in a transaction with Stonepeak in which Stonepeak will acquire a 43.8% stake in Repsol’s Outpost solar project ...

Read more →
11 Dec 2025

Latham & Watkins Advises IRRAS on Sale to ClearPoint Neuro

Latham & Watkins advised IRRAS Holdings Inc. on its sale of 100% of shares to ClearPoint Neuro, Inc. Consideration includes cash, ClearPoint common st...

Read more →
11 Dec 2025

Sullivan & Cromwell Advises Symbotic on $425 Million Registered Common Stock Offering

Sullivan & Cromwell LLP advised Symbotic on an SEC-registered offering of $425 million of common stock, which included the full exercise of the underw...

Read more →
11 Dec 2025

Vinson & Elkins Advises Stonepeak on Acquisition of 43.8% Interest in Outpost Solar Project in Texas

Vinson & Elkins advised Stonepeak in acquiring a 43.8% interest from Repsol in the 629 MW Outpost solar project in Webb County, Texas. The transaction...

Read more →
11 Dec 2025

Latham & Watkins Advises Leerink Partners on Immunovant US$550 Million Common Stock Offering

Latham & Watkins advised underwriter Leerink Partners on Immunovant, Inc.'s underwritten offering of 26.2 million common shares at US$21 per share, ex...

Read more →
11 Dec 2025

Vinson & Elkins Advises Beaver Lake Renewable Energy on 12-Year Carbon Removal Unit Agreement with Microsoft

Vinson & Elkins advised Beaver Lake Renewable Energy LLC (a subsidiary of C2X Ltd) on a long-term agreement with Microsoft for the sale and purchase o...

Read more →
11 Dec 2025

Latham & Watkins Advises Financing Sources on Antero Resources and Antero Midstream Acquisitions of HG Energy Assets

Latham & Watkins LLP advised the financing sources for Antero Resources’ US$2.8 billion acquisition of HG Energy II's upstream assets (including ass...

Read more →
11 Dec 2025

Kirkland & Ellis Advises Arcline on $685 Million Sale of Medical Manufacturing Technologies to Perimeter Solutions

Kirkland & Ellis advised Arcline Investment Management on the $685 million sale of Medical Manufacturing Technologies, LLC (MMT) to Perimeter Solution...

Read more →
11 Dec 2025

Kirkland & Ellis Advises Kellanova on European Commission Approval and Close of $36 Billion Sale to Mars

Kirkland & Ellis served as antitrust counsel to Kellanova, securing unconditional European Commission approval and clearing U.S. FTC review for Kellan...

Read more →
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.